Rezaltas Combination Tablets HD contain Olmesartan medoxomil/azelnidipine, a combination indicated for the treatment of hypertension. Manufactured by Daiichi Sankyo, this 1 tablet formulation with YJ code 2149115F2022 contains 20mg of olmesartan medoxomil and 16mg of azelnidipine.
Rezaltas Combination Tablets HD
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →